CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 42,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale EVP and General Counsel sold 7,000 shares at $22.77 ($159,390)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes EVP and Chief Medical Officer gave up 3,119 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Technical Officer gave up 9,657 shares (to pay taxes)
- 4 Grant or award Chief Technical Officer acquired 5,984 shares (grant or award)
- 4 Shares withheld for taxes EVP and General Counsel gave up 734 shares (to pay taxes)
- 4 Open-market sale Director sold 50,075 shares at an average $25.30 ($1,266,774)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale President and CEO sold 64,768 shares at an average $22.67 ($1,468,425)
- 4 Open-market sale Chief Technical Officer sold 18,235 shares at an average $22.60 ($412,169)
Page 21 of 44 · 872 filings